In 1997 we started a pioneering approach for infection risk management that reduces economic burdens associated with infectious disease worldwide but particularly in developing countries. Its a long term project. In part, donated funds will be used to develop artificial intelligence and vitamins that enrich blood-plasma anti-infection content to help manage opportunistic infections associated with cancers and AIDS in addition to malaria, pneumonia, tuberculosis, influenza and common cold like viruses to include Covid-19 contagion worldwide. 

Collectively opportunistic infections reduce workforce productivity. If successful, in time our effort will reduce sick days taken away from work due to illness or to care for loved ones.  Thank you !